Navigation Links
CardiacAssist, Inc. Surpasses 1300 TandemHeart System Procedures
Date:6/19/2008

Circulatory assist device's high net flow rate supports a multitude of

highly complex procedures in life threatening situations

PITTSBURGH, June 19 /PRNewswire/ -- CardiacAssist, Inc., a Pittsburgh- based medical device company that develops, manufacturers and markets cardiac assist devices, has announced the completion of the 1300th worldwide procedure utilizing the TandemHeart System. This is indicative of TandemHeart's increasing acceptance and use by cardiologists and surgeons. The TandemHeart System is unique in helping heart failure patients survive both heart attacks and high risk procedures, while providing versatility to physicians in choosing the time, place and type of treatments.

The TandemHeart System is now used in over 100 heart centers across the U.S. Ten prestigious heart centers were recently active in helping CardiacAssist, Inc. surpass the 1300th procedure for its TandemHeart System. These ten heart centers include:

-- Brigham & Women's Hospital in Boston, MA

-- Cleveland Clinic in Cleveland, OH

-- Hospital of the University of Pennsylvania in Philadelphia, PA.

-- Lahey Clinic in Burlington, MA

-- Lenox Hill in New York City, NY

-- Mayo Clinic in Rochester, MN

-- Mt. Sinai in New York City, NY

-- Sacred Heart Medical Center in Spokane, WA

-- St. Luke's Hospital in Kansas City, MO

-- Texas Heart Institute in Houston, TX

In each situation the TandemHeart System was selected for its high net flow rate of up to 5 lpm in the Cath Lab or up to 8 lpm in the OR as well as its flexibility and rapid deployment potential. There are a variety of FDA cleared devices that provide extracorporeal circulatory support, but all others offer less than half the net flow and hemodynamic support of the TandemHeart System.

The TandemHeart System is the only 5 lpm net flow, percutaneous "extracorporeal circulatory support" device approved by the FDA for sale in the U.S. Other devices including Impella 2.5 are labeled by the FDA to be used for "partial circulatory support" with less than 2.5 lpm net flow.

The TandemHeart System is fully reimbursed by Medicare under existing DRG codes. The device can be placed rapidly in the cath lab or operating room, providing effective, reliable, temporary circulatory support for critically ill patients.

Contact:

Pamela McDonald

Marketing Assistant

Ph: 412-963-7770 ext. 226

pmcdonald@cardiacassist.com


'/>"/>
SOURCE CardiacAssist, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. MEDRAD Receives FDA 510(k) Clearance for FDG Infusion System
2. NanoInterventions Launches New, Rapid Testing System for Coronary Stents
3. Ahram Biosystems Completes Development of a Palm-Size Portable PCR Device
4. PAREXEL Enhances Early Phase Clinical Development Offering for Central Nervous System Studies
5. Cardiac Science Launches Anywhere Data Management for HIS and EMR Systems
6. Coapt Systems New CEO, Laureen DeBuono, to Fuel Companys Growth and Product Innovation
7. PAL Health Technologies Debuts Xtremityscan System at Western Podiatric Medical Congress
8. Paul J. Mirabella, President and CEO of Naviscan PET Systems Inc., Joins GenVaults Board of Directors
9. Stem Cell Researcher Wins Award for Excellence for Work With the ImageStream(R) System
10. WellCentive Launches New Secure Messaging Platform for Its Patient Registry System
11. Environmental Tectonics Corporations BioMedical Systems Division Awarded Contract for Multiple Monoplace Chambers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 01, 2016 , ... DrugDev believes the only way to ... technology experience. All three tenets were on display at the 2nd Annual DrugDev User ... 40 sponsor, CRO and site organizations to discuss innovation and the future of clinical ...
(Date:12/2/2016)... The immunohistochemistry (IHC) market is projected to reach ... during the forecast period of 2016 to 2021 dominated by immunohistochemistry ... the largest share of immunohistochemistry (IHC) market, by end user.   ... , , ... across 225 pages, profiling 10 companies and supported with 181 tables ...
(Date:11/30/2016)... 2016 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the ... excited to announce the formation of EyGen, Ltd. ... ophthalmology assets through proof of concept. EyGen,s lead ... Portage Pharmaceuticals Limited and being developed for topical ... anterior segment diseases. This agent has the potential ...
(Date:11/30/2016)... BEIJING , Nov. 30, 2016 /PRNewswire/ ... of genomic services and solutions with cutting edge next-generation ... has completed a USD $75 Million [515 Million RMB] ... CMB International Capital Management ( Shenzhen ) ... Ltd. ("SDIC Innovation") and Shanghai Sigma Square Investment Center ...
Breaking Biology Technology:
(Date:11/17/2016)... Nov. 17, 2016  AIC announces that it has just released a new white ... require high-performance scale-out plus high speed data transfer storage solutions. Photo - ... ... ... Setting up a high performance computing or ...
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, ... developing therapeutics focused on the gut microbiome, today ... of 25,000,000 shares of its common stock and ... stock at a price to the public of ... to Synthetic Biologics from the offering, excluding the ...
(Date:11/14/2016)... Inc. ("xG" or the "Company") (Nasdaq: XGTI, XGTIW), a ... challenging operating environments, announced its results for the third ... conference call to discuss these results on November 15, ... Key Recent Accomplishments The ... Vislink Communication Systems. The purchase is expected to close ...
Breaking Biology News(10 mins):